Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26922780 | 1.00 | CCR2 (0.35) | CCR2CTSLCTSB | |
| Hydrochloric Acid SCHEMBL26922663 | 0.99 | CCR2 (0.34) | CCR2CTSLCTSB | |
| Hydrochloric Acid SCHEMBL26922675 | 0.99 | CCR2 (0.34) | CCR2CTSLCTSB | |
| SCHEMBL26947416 | 0.93 | CTSL (0.38) | CTSLCTSB | |
| Hydrochloric Acid SCHEMBL26923310 | 0.92 | CTSL (0.38) | CTSLCTSB | |
| Hydrochloric Acid SCHEMBL26923316 | 0.92 | CTSL (0.38) | CTSLCTSB | |
| SCHEMBL23824408 | 0.87 | MMP1 (0.36) | CTSLCTSB | |
| SCHEMBL30310313 | 0.87 | CTSL (0.39) | CTSLCTSB | |
| SCHEMBL23824709 | 0.87 | MMP1 (0.36) | CTSLCTSB | |
| SCHEMBL29063147 | 0.87 | CTSL (0.39) | CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399296-A1 | RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF | THE GOVERNORS OF THE UNIVERISTY OF ALBERTA (CA) | 2023-12-14 | — | — | US | disclosed |
| WO-2023235970-A1 | RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2023-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399296-A1 | RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF | SARS1, POLRMT, RNASEH1 | CCR2 2810/4885CTSL 917/4885CTSB 934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.